Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
企業コードSMLR
会社名Semler Scientific Inc
上場日Feb 27, 2014
最高経営責任者「CEO」Dr. Douglas Murphy Chutorian, M.D.
従業員数79
証券種類Ordinary Share
決算期末Feb 27
本社所在地51 E Campbell Ave
都市CAMPBELL
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号95008
電話番号18777744211
ウェブサイトhttps://www.semlerscientific.com/
企業コードSMLR
上場日Feb 27, 2014
最高経営責任者「CEO」Dr. Douglas Murphy Chutorian, M.D.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし